Correction: IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma

Y Qiao; C Zhang; A Li; D Wang; Z Luo; Y Ping; B Zhou; S Liu; H Li; D Yue; Z Zhang; X Chen; Z Shen; J Lian; Y Li; S Wang; F Li; L Huang; L Wang; B Zhang; J Yu; Z Qin; Y Zhang

doi:10.1038/s41388-023-02822-3

Correction: IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma

Oncogene. 2023 Oct;42(44):3287-3288. doi: 10.1038/s41388-023-02822-3.

Authors

Y Qiao^#^{1

2}, C Zhang^#^{1

2}, A Li^{1

2}, D Wang^{1

2}, Z Luo^{1

2}, Y Ping¹, B Zhou^{1

3}, S Liu^{1

3}, H Li¹, D Yue^{1

2}, Z Zhang¹, X Chen^{1

2}, Z Shen^{1

2}, J Lian^{1

3}, Y Li^{1

3}, S Wang^{1

2}, F Li¹, L Huang¹, L Wang², B Zhang⁴, J Yu⁵, Z Qin⁶, Y Zhang^{7

8

9

10}

Affiliations

¹ Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
² Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
³ School of Life Sciences, Zhengzhou University, Zhengzhou, China.
⁴ Department of Hematology/Oncology, School of Medicine, Northwestern University, Chicago, IL, USA.
⁵ Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH, USA.
⁶ Medical Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
⁷ Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. yizhang@zzu.edu.cn.
⁸ Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. yizhang@zzu.edu.cn.
⁹ School of Life Sciences, Zhengzhou University, Zhengzhou, China. yizhang@zzu.edu.cn.
¹⁰ Key Laboratory for Tumor Immunology and Biotherapy of Henan Province, Zhengzhou, China. yizhang@zzu.edu.cn.

^# Contributed equally.

PMID: 37723312
DOI: 10.1038/s41388-023-02822-3

No abstract available

Publication types

Published Erratum